Evidence map›Paper›PMID 36899158›Full record

ArticleNature methods2023

Mass spectrometry imaging: the rise of spatially resolved single-cell omics.

Hua Zhang, Daniel G Delafield, Lingjun Li

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Single-Cell Protein Assays in Context: From 2D to 3D and In Situ Analysis.Annual review of analytical chemistry (Palo Alto, Calif.) · 2026
    Review
  6. Image Fusion for Super-Resolution Mass Spectrometry Imaging of Plant Tissue.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hua ZhangSchool of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Daniel G DelafieldDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID http://orcid.org/0000-0003-2989-9833
Lingjun LiSchool of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA. lingjun.li@wisc.edu.ORCID http://orcid.org/0000-0003-0056-3869

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
Acquisition of a Dual-Source, High-Performance, Ion Mobility, Quadrupole Time-of-Flight Mass Spectrometry System for Biomedical Research at UW-MadisonS10OD028473 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI LI, LINGJUN · 2021 to 2021
$1.3M
NIDDK NIH HHS P30 DK020579U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01 DK071801, R01 AG078794, RF1AG052324, P01CA250972U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (OER) S10OD028473, S10RR029531, and S10OD025084
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MetabolomicsMass Spectrometry

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.